Company

Ensysce Biosciences

As of the edition of 20 October 2026, Ensysce Biosciences runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active2
Total2